Michał Chojnacki

9PUBLICATIONS
22CO-AUTHORS
Medical infection agents (incl. prions)Nutritional epidemiologyChemotherapyMolecular targetsOccupational epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2026
The Therapeutic Efficacy of Inhaled Vitamin D3 Metabolites Initiated During the Acute Phase of Hypersensitivity Pneumonitis: An In Vivo Study.

|Dec 30, 2025
Vitamin D3-Deficient Diet Promotes Pulmonary Fibrosis Development in Murine Model of Hypersensitivity Pneumonitis.

Marta Kinga Lemieszek, Michał Chojnacki, Iwona Paśnik

|Sep 27, 2025
First Look at Chemopreventive Properties of Chlorella pyrenoidosa Water Extract in Human Endometrial Adenocarcinoma Cells-Preliminary In Vitro Study.

Weronika Rzeska, Michał Chojnacki, Aneta Adamiak-Godlewska

|Aug 14, 2025
Rasagiline Inhibits Human Melanoma Cell Viability and Interacts Synergistically with Mitoxantrone and Antagonistically with Cisplatin-In Vitro Isobolographic Studies.

Danuta Krasowska, Paula Wróblewska-Łuczka, Michał Chojnacki

|Jun 13, 2025
Cell-Specific Vulnerability of Human Glioblastoma and Astrocytoma Cells to Mephedrone-An In Vitro Study.

Marta Marszalek-Grabska, Marta Kinga Lemieszek, Michal Chojnacki

|Oct 16, 2024
Beneficial Impact of Inhaled 25(OH)-Vitamin D3 and 1,25(OH)2-Vitamin D3 on Pulmonary Response in the Murine Model of Hypersensitivity Pneumonitis.

Marta Kinga Lemieszek, Michał Chojnacki, Iwona Paśnik

Pageof 2

Frequent Collaborators

6 joint publications

Marta Kinga Lemieszek

3 joint publications

Jakub Anisiewicz

3 joint publications

Ilona Leśniowska

2 joint publications

Joanna Jakubowicz-Gil